Handok, Lilly Korea to join forces in Cymbalta

Published: 2010-06-24 06:59:00
Updated: 2010-06-24 06:59:00
Lilly Korea and Handok Pharm said on June 22 that they have agreed to join hands to market Cymbalta (duloxetine HCl) in Korea.

To this end, the two companies exchanged a letter of intent to make Cymbalta more competitive in domestic market.

Cymbalta, part of a class of drugs called serotoni...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.